EDIBLE PLANT-DERIVED NANOPARTICLES FOR REGULATION OF GUT MICROBIOTA

METHOD AND DRUG FOR TREATING NEURONAL CEROID LIPOFUSCINOSIS

METHOD FOR PREPARING LIPOSOMES

Methods and Compositions for RNA-Directed Target DNA Modification and For RNA-Directed Modulation of Transcription

METHODS OF MAKING CIRCULAR RNA

Materials and Methods for Treatment of Human Genetic Diseases Including Hemoglobinopathies

COMPOSITIONS AND METHODS FOR GENE EDITING BY TARGETING TRANSFERRIN

Antisense Nucleic Acids

OLIGONUCLEOTIDES TARGETING RNA BINDING PROTEIN SITES

MULTI-FUNCTIONAL COMBINATION OUTLINE TOOL

COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO CELLULAR SENESCENCE

ENHANCED EXPRESSION OF ALTERNATIVE SPLICED UROMODULIN FOR THERAPEUTICUSE

OLIGONUCLEOTIDES WITH ETHYLENE GLYCOL MODIFICATION

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

TRANS-SPLICING RNA (TSRNA)

ENHANCED IMMUNE EFFECTOR CELLS AND USE THEREOF

T CELLS WITH IMPROVED FUNCTIONALITY

Ventricular Arrhythmias and Related Methods

METHODS, COMPOSITIONS, AND DEVICES INVOLVING PSEUDOKNOT FORMATION

ORGANELLE GENOME MODIFICATION USING POLYNUCLEOTIDE GUIDED ENDONUCLEASE

ANTISENSE OLIGONUCLEOTIDES TARGETING ALPHA-SYNUCLEIN AND USES THEREOF

CHANNEL MODULATORS

MODULATORS OF MALAT1 EXPRESSION

miR-141-3p MODULATORS AND USES THEREOF

OLIGONUCLEOTIDE AGONISTS TARGETING PROGRANULIN

Composition and Methods for Modulating Nuclear Enriched Abundant Transcript 1 to Treat Cognitive Impairment

MODULATION OF ALPHA SYNUCLEIN EXPRESSION

COMPOSITIONS AND METHODS COMPRISING ENGINEERED SHORT NUCLEAR RNA (SNRNA)

MODULATION OF MICRORNA-335-5P FOR THE TREATMENT OF SODIUM CHANNELOPATHIES

Methods and Compositions for Avoiding Off-Target Effects

iRNA Compositions and Methods for Silencing ANGPTL4

NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF COMPLEMENT FACTOR B (CFB) IN A CELL

USE OF ETV3 OR ETV6 INHIBITORS FOR BLOCKING THE DIFFERENTIATION OF MONOCYTES INTO DENDRITIC CELLS

METHODS TO ACCELERATE STEM CELL DIFFERENTIATION TO CARDIOMYOCYTES

RECOMBINANT OPTIMIZED MECP2 CASSETTES AND METHODS FOR TREATING RETT SYNDROME AND RELATED DISORDERS

COMPOSITIONS FOR EDITING MECP2 TRANSCRIPTS AND METHODS THEREOF

CELL-PENETRATING PEPTIDES FOR ANTISENSE DELIVERY

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING AUTOIMMUNE DISEASES

Treatment Of Myeloid Cell Dysfunction With Membrane Spanning 4-Domains A6A (MS4A6A) Inhibitors

OPTIMIZED SEQUENCES FOR ENHANCED tRNA EXPRESSION OR/AND NONSENSE MUTATION SUPPRESSION

NANOPARTICLE VECTOR FOR RNA SELF-DELIVERY, AND PREPARATION METHOD THEREFOR AND USE THEREOF

METHODS AND COMPOSITIONS FOR TARGETED GENOMIC INSERTION

Treatment Of Liver Disease Or Metabolic Disorder With Folliculin Interacting Protein 1 (FNIP1) Inhibitors And/Or Folliculin (FLCN) Inhibitors

COMPOUNDS AND METHODS FOR SKIPPING EXON 44 IN DUCHENNE MUSCULAR DYSTROPHY

CRISPR/CAS SCREENING PLATFORM TO IDENTIFY GENETIC MODIFIERS OF TAU SEEDING OR AGGREGATION

EPO RECEPTOR AGONISTS AND ANTAGONISTS

EPO RECEPTOR AGONISTS AND ANTAGONISTS

CD71 BINDING FIBRONECTIN TYPE III DOMAINS

COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES

ANISAMIDE-CONTAINING LIPIDS AND COMPOSITIONS AND METHODS OF USE THEREOF

MICRORNA INHIBITOR THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS

Methods and Compositions for RNA-Directed Target DNA Modification and for RNA-Directed Modulation of Transcription

NOVEL CAS9 ORTHOLOGS

RNAi OLIGONUCLEOTIDE CONJUGATES

ARTIFICIAL NUCLEIC ACIDS FOR RNA EDITING

LIPID NANOPARTICLES

OLIGONUCLEOTIDES FOR INDUCING PATERNAL UBE3A EXPRESSION

SIMULTANEOUS GENE EDITING AND HAPLOID INDUCTION

SNCA-TARGETING SIRNA COMPOSITIONS FOR TREATING SNCA-ASSOCIATED DISEASE

MODULATING THE CELLULAR STRESS RESPONSE

COMPOUNDS FOR INHIBITING AMANZI

METHOD OF INTERFERING WITH REPETITIVE RNA

COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION OF LPA

SCHWANN CELL-SPECIFIC PROMOTER

Methods of Rescuing Stop Codons via Genetic Reassignment with ACE-tRNA

EXTRACELLULAR VESICLE-ASO CONSTRUCTS TARGETING STAT6

GENERATION OF INDUCED PLURIPOTENT CELLS BY CRISPR ACTIVATION

THERAPEUTIC APPLICATIONS OF CPF1-BASED GENOME EDITING

LIPID NANOPARTICLE (LNP) COMPOSITIONS FOR BRAIN-SELECTIVE CARGO DELIVERY, AND METHODS OF USE THEREOF

THERAPY FOR POLYCYSTIC KIDNEY DISEASE

PRE-MRNA SLICE MODULATING PEPTIDE-CONJUGATED ANTISENSE THERAPEUTICS FOR THE TREATMENT OF DISEASES

METHODS FOR ENHANCING THERAPEUTIC EFFICACY OF ISOLATED CELLS FOR CELL THERAPY

METHOD OF DELIVERY OF DNA OR RNA CARGO USING UNSHIELDED LIPID NANOPARTICLES AND COMPOSITIONS THEREOF

HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS

RIG1 Inhibition and Therapeutic Viral Protein Expression

SIGNAL BOOST CASCADE ASSAY

COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASE

RNA MOLECULE

COMPOUNDS AND METHODS FOR MODULATING PROGRANULIN EXPRESSION

S. PYOGENES CAS9 MUTANT GENES AND POLYPEPTIDES ENCODED BY SAME

COMPOUNDS AND METHODS FOR THE MODULATION OF PROTEINS

TRIGGER NUCLEIC ACIDS AND RNA-BINDING PROTEINS FOR UPREGULATING GENE EXPRESSION

COMPOSITIONS AND METHODS OF USING PRKAG2-TARGETING ANTIBODY-OLIGONUCLEOTIDE CONJUGATES

COMPOSITIONS FOR AQUACULTURING

VECTOR-FREE INTRACELLULAR DELIVERY BY REVERSIBLE PERMEABILISATION

COMPOSITIONS AND METHODS TO TREAT CANCER

DEAMINASE-BASED RNA SENSORS

NANOPARTICLES FUNCTIONALIZED WITH GENE EDITING TOOLS AND RELATED METHODS

MIRNA CIRCUITS FOR CONTROLLED GENE EXPRESSION

ADVANCED RNA TARGETING (ARNATAR)

METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT

OLIGONUCLEOTIDE MODULATORS ACTIVATING UTROPHIN EXPRESSION

MODIFIED siRNA FOR SELECTIVELY INHIBITING EXPRESSION OF MUTANT FUS

ALLELE SPECIFIC SPLICE SWITCHING OLIGONUCLEOTIDES TARGETING PSEUDOEXONS

CHEMICALLY MODIFIED ANTISENSE OLIGONUCLEOTIDES (ASOS) AND COMPOSITIONS COMPRISING THE SAME FOR RNA EDITING

Implantable Medical Device for the Delivery of a Nucleic Acid

METHODS AND COMPOSITIONS FOR CARDIAC MODELS

ANTI-IL-23 ANTIBODIES

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FRIEDREICH'S ATAXIA

TARGETED COMPOSITIONS

COMPOSITIONS AND METHODS FOR TREATING BACTERIAL DISEASE

COMPOSITIONS AND METHODS FOR TREATING ALLERGIC INFLAMMATORY CONDITIONS

LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF

Method for Regulating and Controlling Heterologous Synthetic Flavonoid Compound and Use Thereof

MICRORNA-198 AS A TUMOR SUPPRESSOR IN OVARIAN CANCER

GENE THERAPY TARGETING THE NEONATAL FORM OF NAV1.5 FOR TREATING CANCER

POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE

RIBOZYME-ASSISTED CIRCULAR RNAS AND COMPOSITIONS AND METHODS OF USE THEREOF

Treatment Of Osteoarthritis With Cartilage Intermediate Layer Protein 2 (CILP2) Inhibitors

A GLUN2D INHIBITOR FOR USE IN THE TREATMENT OR RELAPSE PREVENTION OF A DEPRESSIVE EPISODE

BANCR Compositions and Methods for Treating Disease

EXON SKIPPING OLIGOMERS AND OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY

ANTISENSE OLIGONUCLEOTIDES AND THEIR USE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS

PROMOTERS FOR VIRAL-BASED GENE THERAPY

SYSTEMS, METHODS, AND COMPOSITIONS FOR SITE-SPECIFIC GENETIC ENGINEERING USING PROGRAMMABLE ADDITION VIA SITE-SPECIFIC TARGETING ELEMENTS (PASTE)

GUIDE RNA WITH CHEMICAL MODIFICATIONS

MICRORNA-33 INHIBITORS AND USE THEREOF IN THE TREATMENT OF PULMONARY FIBROSIS

PROMOTION SYSTEM FOR CELLULAR PROTEIN SYNTHESIS AND USE THEREOF

Trialkyne Linking Agents and Methods of Use

Cationic Hyperbranched Starch-based Gene Carrier, Preparation Method and Application Thereof

METHODS OF TREATING OR PREVENTING PREMATURE OVARIAN INSUFFICIENCY, POLYCYSTIC OVARY SYNDROME, OR INFERTILITY USING EXOSOMES OR MESENCHYMAL STEM CELLS

EXON SKIPPING OLIGOMERS AND OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY

Neurosome/Astrosome Compositions and Methods of Use

CANNULA SYSTEM AND USE THEREOF

TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)

NONVIRAL VECTORS FOR GENE THERAPY

METHODS AND COMPOSITIONS TO REGULATE MAPT SPLICING FOR MODELING AND TREATMENT OF TAUOPATHIES

Antisense Nucleic Acids

Antisense Nucleic Acid

RECRUITMENT OF DNA POLYMERASE FOR TEMPLATED EDITING

RNA ENCODING A THERAPEUTIC PROTEIN

METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING A DISEASE OR DISORDER ASSOCIATED WITH ABNORMAL LEVEL AND/OR ACTIVITY OF THE IFP35 FAMILY OF PROTEINS

LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS

LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS

TREATMENT OF BRAIN TUMORS BY TARGETING THE CHOLESTEROL PATHWAY IN ASTROCYES

METHODS FOR ATTENUATING VIRAL INFECTION AND FOR TREATING LUNG INJURY

SYSTEMS OF ENGINEERED RECEPTORS TARGETING PSMA AND CA9

Method of Targeting Cells and Associated Compositions

CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS

NUCLEIC ACID-GUIDED NUCLEASES

WPRE MUTANT CONSTRUCTS, COMPOSITIONS, AND METHODS THEREOF

COMPOSITIONS AND METHODS FOR MODULATING NEURONAL EXCITABILITY AND MOTOR BEHAVIOR

RNAi Agents for Inhibiting Expression of Inhibin Subunit Beta E (INHBE), Pharmaceutical Compositions Thereof, and Methods of Use

METHODS AND COMPOSITIONS FOR TREATING CARDIOMYOPATHY

L-RNA APTAMERS, RECOMBINANT POLYNUCLEOTIDES, AND USES THEREOF IN TREATING ALZHEIMERS DISEASE

TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES

TARGETING THE YTHDF1/ARHGEF2 AXIS FOR CANCER TREATMENT

RNAS FOR COMPLEMENT INHIBITION

OLIGONUCLEOTIDE-LIGAND CONJUGATES AND PROCESS FOR THEIR PREPARATION

METHOD FOR IMPROVING WOUND HEALING

DOUBLE-STRANDED RNA HAVING NUCLEOTIDE ANALOG

NOVEL CATIONIC LIPID COMPOUNDS

MODIFIED AMINE LIPIDS

HYPERBRANCHED POLY(BETA-AMINO ESTER) FOR SIRNA DELIVERY AND GENE SILENCING

SMALL MOLECULE AND SIRNA INHIBITORS AGAINST LIPOCALIN-2

DETECTION OF GENETIC VARIANTS OF THE BETA-ADRENERGIC RECEPTOR PATHWAY FOR DETECTING AND TREATING RETINOPATHY OF PREMATURITY

UNNATURAL BASE PAIR COMPOSITIONS AND METHODS OF USE

ANGELMAN SYNDROME ANTISENSE TREATMENT

MODULATORS OF APOL1 EXPRESSION

THERAPEUTIC OLIGONUCLEOTIDES

POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE

Novel Retinitis Pigmentosa Treatment

METHODS FOR TREATING CONDITIONS AND DISEASES

OLIGONUCLEOTIDES WITH INTERNUCLEOTIDE LINKAGE MODIFICATIONS FOR KIDNEY TARGETING

Advanced RNA targeting (ARNATAR) for angiotensinogen

METHODS AND MATERIALS FOR TREATING HEART ATTACK

METHODS AND AGENTS FOR INCREASING RBM3 EXPRESSION

ANTISENSE OLIGOMERS FOR TREATMENT OF CHRONIC KIDNEY DISEASE

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF

COMPOSITIONS AND METHODS FOR TRANSFER USING CER1

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject

Materials and Methods for Treatment of Duchenne Muscular Dystrophy

AMYLOID PRECURSOR PROTEIN (APP) RNAi AGENTS

MULTIVALENT CARGO-CARRYING COMPLEXES AND USES THEREOF

ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

DEGRADABLE LIPID COMPOUND FOR ACTIVE MOLECULE DELIVERY AND NANOCOMPLEX THEREOF

IONIZABLE LIPIDS FOR MULTIPLE ORGAN TARGETING

COMPOSITIONS AND METHODS FOR INHIBITION OF HAO1 (HYDROXYACID OXIDASE 1 (GLYCOLATE OXIDASE)) GENE EXPRESSION

Heterocyclic Carboxylate Compounds as Glycolate Oxidase Inhibitors

COMPOSITIONS FOR THE DELIVERY OF tRNA AS NANOPARTICLES AND METHODS OF USE THEREWITH

ANALYSIS OF NUCLEIC ACIDS ASSOCIATED WITH SINGLE CELLS USING NUCLEIC ACID BARCODES

METHODS AND COMPOSITIONS FOR TARGETED TRANS-SPLICING

CELL DEATH-INDUCING DFFA-LIKE EFFECTOR B (CIDEB) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

SNCA-TARGETING SIRNA COMPOSITIONS FOR TREATING SNCA-ASSOCIATED DISEASE

DOUBLE STRANDED RNA TARGETING ANGIOPOIETIN-LIKE 3 (ANGPTL-3) AND METHODS OF USE THEREOF

SGLT-2 TARGETING OLIGONUCLEOTIDES

COMPOSITIONS AND METHODS OF tRNA SILENCING

THERAPEUTIC OLIGONUCLEOTIDES HAVING AN INTER-NUCLEOSIDE AMIDE LINKAGE

TUNABLE REVERSIR TM COMPOUNDS

OPA1 ANTISENSE OLIGOMERS FOR TREATMENT OF CONDITIONS AND DISEASES

ANTISENSE OLIGONUCLEOTIDES (ASO) FOR EFFICIENT AND PRECISE RNA EDITING WITH ENDOGENOUS ADENOSINE DEAMINASE ACTING ON RNA (ADAR)

METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING A DISEASE OR DISORDER ASSOCIATED WITH ABNORMAL LEVEL AND/OR ACTIVITY OF THE IFP35 FAMILY OF PROTEINS

Guide RNA That Targets A Mutant Human Guanylate Cyclase 2A Allele

COMPOSITION FOR PROMOTING MIGRATION OF ADULT STEM CELLS USING INCREASE IN EXPRESSION OF MIRNA

NUCLEIC ACID, COMPOSITION AND CONJUGATE CONTAINING NUCLEIC ACID, PREPARATION METHOD THEREFOR AND USE THEREOF

Compositions And Methods Targeting G12 Signaling For Bronchodilator Therapy

COMPOSITIONS FOR RNA-PROTEIN TETHERING AND METHODS OF USING

OLIGONUCLEOTIDES FOR MODULATING TAU EXPRESSION

COMPOSITIONS AND METHODS OF MODULATING LONG NONCODING TRANSCRIPTS ASSOCIATED WITH ARDS INDUCED PULMONARY FIBROSIS

THERAPEUTICS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

DIRECT PRODUCTION OF SIRNAS IN SACCHAROMYCES BOULARDII AND PACKAGING IN EXTRACELLULAR VESICLES (EVs) FOR TARGETED GENE SILENCING

DNAZYME AND USE THEREOF

Antisense Oligonucleotide for Targeting Progranulin

MULTIVALENT CARGO-CARRYING COMPLEXES AND USES THEREOF

COMPOSITIONS COMPRISING THERAPEUTIC NUCLEIC ACID AND SAPONIN FOR THE TREATMENT OF MUSCLE-WASTING DISORDERS

ANTISENSE OLIGONUCLEOTIDE TARGETING ATN1 MRNA OR PRE-MRNA

NON-CODING RNA-MEDIATED NEUROLOGICAL DISEASE TREATMENT

iRNA Compositions and Methods for Silencing MYLIP

TREATMENT OF NEUROLOGICAL DISEASES USING MODULATORS OF UNC13A GENE TRANSCRIPTS

APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR REGULATING PRODUCTION OF AN ANTIBODY LIKE PROTEIN AND RIBONUCLEIC ACID

COMPOSITIONS AND METHODS FOR MODULATING INTERFERON REGULATORY FACTOR-5 (IRF-5) ACTIVITY

TREATING & PREVENTING E COLI INFECTIONS

TRANSMISSIBLE ELEMENTS COMPRISING PATHWAY MODIFICATION SYSTEMS AND EXOGENOUS NUCLEIC ACIDS FOR THE PRODUCTION OF MOLECULES OF INTEREST

PRODUCTS AND COMPOSITIONS

SYNTHETIC MEMORY WITH INTERCEPTING RECOMBINASE FUNCTION

METHODS AND COMPOSITIONS FOR INHIBITING DETOXIFICATION RESPONSE

Mammalian ATG8 Proteins and ATG9A Direct Sealing of Autophagosomal Membranes

OLIGONUCLEOTIDES FOR SNCA MODULATION

PROCESSES FOR PREPARING PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS VIA FAST-FLOW SYNTHESIS

ATTENUATED ORTHOMYXOVIRUS-BASED VECTOR PLATFORM

TREATMENT OF FGG RELATED DISEASES AND DISORDERS

ANTISENSE OLIGONUCLEOTIDE FOR USE IN THE TREATMENT OF PSORIASIS-INDUCED ITCHING AND PHOSPHOLIPID VESICLE COMPRISING SAID OLIGONUCLEOTIDE

SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

NON-INTEGRATING VIRAL DELIVERY SYSTEM AND METHODS RELATED THERETO

ANTISENSE NUCLEIC ACIDS

COMPOSITIONS AND METHODS FOR PREVENTION OR REDUCTION OF CARPA

EXTRACTION OF PLANT SOURCE "MEDICINAL SOUP" AND MANUAL PREPARATION OF "HERBAL MEDICINE" AND RELATED PRODUCTS

MUTANT MYOCILIN DISEASE MODEL AND USES THEREOF

MODIFIED DOUBLE-STRANDED RNA AGENTS

NON-LIPOSOMAL SYSTEMS FOR NUCLEIC ACID DELIVERY

STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) CHAPERONE (SCAP) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

ANTISENSE OLIGONUCLEOTIDE DRUG TARGETS

CONSTRUCTS COMPRISING TANDEM MICRORNA-ADAPTED SHORT HAIRPIN RNA (SHMIR) FOR INCREASING FETAL HEMOGLOBIN

CELL DEATH-INDUCING DFFA-LIKE EFFECTOR B (CIDEB) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

GLYCAN CONJUGATE COMPOSITIONS AND METHODS

Methods and Compositions for ADAR-Mediated Editing

Methods and Compositions for ADAR-Mediated Editing

COMPOSITIONS AND METHODS FOR IMPROVING THE EFFICACY OF CAS9-BASED KNOCK-IN STRATEGIES

Novel Compositions for Conjugating Oligonucleotides and Carbohydrates

TARGETED VESICLE COMPOSITIONS AND METHODS

COMPOSITIONS AND METHODS OF USING PLN-TARGETING ANTIBODY-OLIGONUCLEOTIDE CONJUGATES

METHOD FOR TREATING NEURODEGENERATIVE DISEASES

DNA mapping and sequencing on linearized DNA molecules

TEMPERATURE-BASED TRANSIENT DELIVERY OF NUCLEIC ACIDS AND PROTEINS TO CELLS AND TISSUES

DNA COMPOSITIONS AND RELATED METHODS

COMPOSITIONS AND METHODS FOR MANAGEMENT OF WHITEFLY

Target gene expression control system comprising dxCas9 and CRP derivative and preparation method therefor

COMPOSITIONS AND METHODS FOR TREATMENT OF CANCERS USING MODIFIED siRNA-GEM AGENTS

COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE UTILIZING A TRANSCRIPTIONAL MASTER REGULATOR OF THE RETROMER COMPLEX

COMPOSITIONS FOR INHIBITING DIPEPTIDE REPEAT PROTEIN-RIBOSOMAL RNA INTERACTION AND USES THEREOF

USE OF MIRNA-2911 MOLECULE AS NUCLEIC ACID STABILIZER

STAGGERED TRIPLE LIPID-MODIFIED NUCLEIC ACID COMPOUNDS

METHODS AND COMPOSITIONS FOR INHIBITING PMP22 EXPRESSION

COMPLEMENT FACTOR B (CFB) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

USE OF FANA ANTISENSE OLIGONUCLEOTIDES FOR THE PREVENTION AND MANAGEMENT OF HUANGLONGBING AND ZEBRA CHIP DISEASES

ENGINEERED NUCLEASES THAT TARGET HUMAN AND CANINE FACTOR VIII GENES AS A TREATMENT FOR HEMOPHILIA A

Compositions And Methods For Differentiation Of Human Pluripotent Stem Cells Into Desired Cell Types

MUSCLE TARGETING COMPLEXES FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

TISSUE-SPECIFIC IMAGING AND THERAPEUTIC AGENTS TARGETING PROTEINS EXPRESSED ON MUSCLE CELL SURFACE

MESENCHYMAL STROMAL CELL DELIVERY VIA CARDIOPULMONARY BYPASS PROVIDES NEUROPROTECTION

THERAPEUTIC NUCLEIC ACIDS AND METHODS OF USE THEREOF

ANTICANCER COMPOSITIONS AND METHODS FOR MAKING AND USING THEM

HOMEOBOX TRANSCRIPTION FACTOR VENTX REGULATES DIFFERENTIATION AND MATURATION OF HUMAN DENDRITIC CELLS

Deaminase-Based RNA Sensors

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING TARGET CANCER INCLUDING BRCA-SPECIFIC siRNA AS ACTIVE INGREDIENT

ANTITUMORAL COMPOSITION

PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF BLOOD CANCER COMPRISING SURF4 INHIBITOR

GATA4-TARGETED THERAPEUTICS FOR TREATMENT OF CARDIAC HYPERTROPHY

TREATMENT FOR INFLAMMATORY DISEASE

TREATING CHEMORESISTANT FORMS OF LEUKEMIA AND OTHER CANCERS THAT OVEREXPRESS RNA BINDING PROTEIN FXR1

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE

IRNA COMPOSITIONS AND METHODS FOR SILENCING COMPLEMENT COMPONENT 3 (C3)

MODIFIED U6 PROMOTER SYSTEM FOR TISSUE SPECIFIC EXPRESSION

USE OF GANODERMA FUNGAL RNA MOLECULES, DRUG, DRUG COMPOSITION AND DELIVERY CARRIER

ENGINEERED CELL LINES FOR INCREASED PRODUCTION OF RECOMBINANT ADENO-ASSOCIATED VIRUS (RAAV)

DOSING OF MUSCLE TARGETING COMPLEXES FOR TREATING DYSTROPHINOPATHIES

LIPID-BASED CONJUGATES FOR SYSTEMIC, CENTRAL NERVOUS SYSTEM, PERIPHERAL NERVOUS SYSTEM, AND OCULAR DELIVERY

PHARMACEUTICAL COMPOSITION FOR PROMOTING CANCER IMMUNOTHERAPY AND METHOD FOR PROMOTING CANCER IMMUNOTHERAPY

LACTATE DEHYDROGENASE A (LDHA) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

YEAST STRAIN FOR MOSQUITO MANAGEMENT

Compositions and Methods for Modulating Single Stranded DNA Regions that Catalyze Enzymatic Reactions

RNA MODULATING OLIGONUCLEOTIDES WITH IMPROVED CHARACTERISTICS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS

GENE THERAPY FOR NEURODEGENERATIVE DISORDERS

ARTIFICIAL YEAST PROMOTER REGIONS

METHODS AND COMPOSITIONS TARGETING NUCLEUS ACCUMBENS-ASSOCIATED PROTEIN-1 FOR TREATMENT OF AUTOIMMUNE DISORDERS AND CANCERS

COMPOSITIONS OF HUMAN HEART DERIVED EXTRACELLULAR VESICLES AND USES THEREOF

COMPOSITIONS AND METHODS FOR ENHANCING GENE SILENCING ACTIVITY OF OLIGONUCLEOTIDE COMPOUNDS

APP iRNA Compositions and Methods of Use Thereof for Treating or Preventing Diseases Characterized by Enlarged Endosomes

DELIVERY OF ANITSENSE OLIGOMERS BY MIRROR IMAGE PEPTIDES

HUNTINGTIN (HTT) IRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

Engineered Guide RNAs and Polynucleotides

ANTISENSE COMPOUNDS AND METHODS FOR TARGETING CUG REPEATS

COMPOSITIONS AND METHODS FOR TREATING TDP-43 PROTEINOPATHY

NEURODEGENERATIVE DISORDERS

METHODS OF EDITING WITH ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS

TARGETING APOE ENHANCES T-CELL KILLING IN CANCER IMMUNOTHERAPY

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF MAKING THE SAME